4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-000995
Director sold 10,000 shares at $50.01 ($500,060)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Henderson Jeffrey William · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-06 | Sale : show line 1 in the form 10b5-1 | −10,000 | $50.01 | $500,060 | 43,611 | D |
| Open-market sales · 10,000 sh · avg $50.01 · $500,060 | ||||||
Loading xslF345X05/form4-01072025_090159.xml…